Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sezary Syndrome 1Sarcoma, Synovial 1Rectal Neoplasms 1Ovarian Neoplasms 1Mycosis Fungoides 1Liposarcoma, Myxoid 1HIV Infections 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 4pazopanib 2cixutumumab 2Radiotherapy 2Ifosfamide 2sapanisertib 1romidepsin 1peposertib 1pembrolizumab 1pegfilgrastim 1liposomal doxorubicin 1ixabepilone 1interferon gamma-1b 1Trastuzumab 1Temozolomide 1Specimen Handling 1Sorafenib 1Radiation 1Molecular Diagnostic Techniques 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Interferon-gamma 1Imatinib Mesylate 1HhAntag691 1Filgrastim 1Everolimus 1Etoposide 1Diathermy 1Biopsy 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Synovial × interferon gamma-1b × Clear all
NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡